T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| 1 |
Equifax
EFX
|
$760M |
| 2 |
Xcel Energy
XEL
|
$577M |
| 3 |
Linde
LIN
|
$572M |
| 4 |
Intercontinental Exchange
ICE
|
$549M |
| 5 |
AbbVie
ABBV
|
$530M |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
$948M |
| 2 |
TE Connectivity
TEL
|
$731M |
| 3 |
Yum! Brands
YUM
|
$724M |
| 4 |
Becton Dickinson
BDX
|
$718M |
| 5 |
Ingersoll Rand
IR
|
$664M |
Sector Composition
| 1 | Technology | 23.66% |
| 2 | Healthcare | 22.34% |
| 3 | Financials | 13.96% |
| 4 | Industrials | 11.89% |
| 5 | Consumer Discretionary | 11.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
526
Fate Therapeutics
FATE
$112M
| $4.38M | ﹤0.01% |
433,869
+27,725
| +7% | +$280K |
|
527
ThredUp
TDUP
$1.44B
| $3.41M | ﹤0.01% |
2,598,755
-655,748
| -20% | -$859K |
|
528
Mister Car Wash
MCW
$1.85B
| $3.4M | ﹤0.01% |
+368,731
| New | +$3.4M |
|
529
NovoCure
NVCR
$1.34B
| $3.31M | ﹤0.01% |
+45,059
| New | +$3.31M |
|
530
Tenaya Therapeutics
TNYA
$202M
| $3.15M | ﹤0.01% |
1,564,745
| – | – |
|
|
VZIO
531
DELISTED
VIZIO Holding Corp.
VZIO
| $2.89M | ﹤0.01% |
+389,450
| New | +$2.89M |
|
532
Eventbrite
EB
$253M
| $2.83M | ﹤0.01% |
483,154
-31,572
| -6% | -$185K |
|
533
Olaplex Holdings
OLPX
$974M
| $2.58M | ﹤0.01% |
494,396
-1,562,878
| -76% | -$8.14M |
|
534
Rapid Micro Biosystems
RPID
$108M
| $2.48M | ﹤0.01% |
2,194,185
-452,427
| -17% | -$511K |
|
535
Immuneering
IMRX
$233M
| $2.22M | ﹤0.01% |
458,233
| – | – |
|
536
Grocery Outlet
GO
$1.78B
| $1.89M | ﹤0.01% |
64,766
-61,760
| -49% | -$1.8M |
|
|
HZN
537
DELISTED
Horizon Global Corporation
HZN
| $1.77M | ﹤0.01% |
4,561,534
| – | – |
|
538
Hydrofarm Holdings
HYFM
$14.1M
| $1.2M | ﹤0.01% |
77,347
+54,011
| +231% | +$837K |
|
|
BOAC.WS
539
DELISTED
Bluescape Opportunities Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
BOAC.WS
| $106K | ﹤0.01% |
659,463
-1,488,512
| -69% | -$239K |
|
|
ADVWW
540
Advantage Solutions Warrant
ADVWW
| $81K | ﹤0.01% |
579,413
| – | – |
|
541
ABM Industries
ABM
$2.99B
| – | – |
-710,358
| Closed | -$27.2M |
|
542
Alkermes
ALKS
$4.77B
| – | – |
-4,562,808
| Closed | -$102M |
|
543
Array Technologies
ARRY
$1.39B
| – | – |
-2,086,179
| Closed | -$34.6M |
|
544
C4 Therapeutics
CCCC
$190M
| – | – |
-547,667
| Closed | -$4.8M |
|
545
Deckers Outdoor
DECK
$18.4B
| – | – |
-3,019,578
| Closed | -$157M |
|
546
DraftKings
DKNG
$23.5B
| – | – |
-8,077,070
| Closed | -$122M |
|
547
DocuSign
DOCU
$15.4B
| – | – |
-2,518,551
| Closed | -$135M |
|
548
Exelixis
EXEL
$10.1B
| – | – |
-4,700,190
| Closed | -$73.7M |
|
549
Genius Sports
GENI
$3.23B
| – | – |
-1,906,493
| Closed | -$7M |
|
|
550
Alphabet (Google) Class C
GOOG
$2.81T
| – | – |
-9,859,680
| Closed | -$948M |
|